Clinical trials
Phase 1 Lymphoma, T-Cell trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| iCell Gene Therapeutics | 3 |
| BGI, China | 1 |
| Fundamenta Therapeutics, Ltd. | 1 |
| Hebei Senlang Biotechnology Inc., Ltd. | 1 |
| Lanzhou Institute of Biological Products Co., Ltd | 1 |
| Legend Biotech USA Inc | 1 |
| Oncotartis, Inc. | 1 |
| Peking University People's Hospital | 1 |
| The First Affiliated Hospital of Bengbu Medical University | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 14 |
| Leukemia, T-Cell | 4 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Lymphoma | 3 |
| Hodgkin Disease | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Epstein-Barr Virus Infections | 1 |
| Immunoblastic Lymphadenopathy | 1 |
| Leukemia, Prolymphocytic, T-Cell | 1 |
| Lymphoma, B-Cell | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.